Today: 17 January 2026
Subscribe
Browse Category

Medical Technology News 13 December 2025 - 2 January 2026

Intuitive Surgical stock falls today: what’s driving ISRG and what investors watch next

Intuitive Surgical stock falls today: what’s driving ISRG and what investors watch next

NEW YORK, January 2, 2026, 3:30 PM ET — Regular session Intuitive Surgical shares slid 1% to $560.61 in afternoon trading on Friday, lagging a mixed U.S. tape in the market’s first session of 2026. The drop matters because investors are starting the year with fresh sensitivity to valuation—how much they are paying for a dollar of earnings—after a strong…
2 January 2026
····
Bupa renews ParalympicsGB partnership and seals Nuffield Health deal as robotic knee surgery hits 1,000 mark

Bupa renews ParalympicsGB partnership and seals Nuffield Health deal as robotic knee surgery hits 1,000 mark

NEW YORK, January 1, 2026, 06:51 ET Bupa UK on Wednesday renewed its role as Official Healthcare Partner of ParalympicsGB and agreed a new three-year contract between Bupa UK Insurance and Nuffield Health, the company said. The Nuffield agreement adds direct appointment booking and wider access to diagnostics for Bupa customers. (Source) The moves matter because speed to diagnosis is…
1 January 2026
··
Heartflow stock drops nearly 3% today as year-end trading thins; what investors watch next

Heartflow stock drops nearly 3% today as year-end trading thins; what investors watch next

NEW YORK, December 31, 2025, 13:57 ET — Regular session Heartflow Inc shares fell 2.8% to $29.35 by early afternoon on Wednesday, after trading between $29.26 and $30.97. Volume was about 336,000 shares. The drop outpaced a small decline in the broader market, with the S&P 500 tracker SPY down about 0.2% and the Nasdaq 100 tracker QQQ off roughly…
31 December 2025
···
Intuitive Surgical (ISRG) Stock: What to Know Before the Market Opens on Dec. 26, 2025

Intuitive Surgical (ISRG) Stock: What to Know Before the Market Opens on Dec. 26, 2025

Intuitive Surgical, Inc. (NASDAQ: ISRG) heads into the Friday, December 26, 2025 U.S. trading session with investor attention split between strong operating momentum in robotic-assisted surgery and a fresh mix of regulatory and corporate updates that could shape near-term sentiment. After the last regular U.S. session ahead of today’s open, ISRG shares were around $577.15. Below is what investors and…
26 December 2025
····
Intuitive Surgical (ISRG) News, Analyst Forecasts and 2026 Outlook: FDA Expansion for da Vinci SP, Wall Street Targets, and What’s Next (Dec. 25, 2025)

Intuitive Surgical (ISRG) News, Analyst Forecasts and 2026 Outlook: FDA Expansion for da Vinci SP, Wall Street Targets, and What’s Next (Dec. 25, 2025)

December 25, 2025 — Intuitive Surgical, Inc. (NASDAQ: ISRG) is ending 2025 with two storylines that rarely move in sync: fresh regulatory momentum for its single-port robotic platform and a renewed valuation debate as analysts model what the next wave of procedure growth could look like in 2026. With U.S. markets closed for Christmas Day, ISRG was last quoted around…
25 December 2025
···
Abbott Laboratories (ABT) News and Stock Outlook on Dec. 25, 2025: FDA Clears Volt PFA, FreeStyle Libre Alert Persists, Exact Sciences Deal Looms

Abbott Laboratories (ABT) News and Stock Outlook on Dec. 25, 2025: FDA Clears Volt PFA, FreeStyle Libre Alert Persists, Exact Sciences Deal Looms

Dec. 25, 2025 — Abbott Laboratories (NYSE: ABT) heads into the year-end stretch with a rare mix of near-term product momentum and headline-level risk management. Over the past several weeks—culminating in key December announcements—Abbott has (1) secured U.S. FDA approval for a next-generation atrial fibrillation ablation platform, (2) expanded its push into consumer biowearables, (3) navigated an FDA early alert…
25 December 2025
····
Intuitive Surgical Stock (ISRG) Week Ahead: FDA da Vinci 5 Recall Posting, da Vinci SP Expansion, and Fresh Wall Street Targets Into the Christmas Trading Week

Intuitive Surgical Stock (ISRG) Week Ahead: FDA da Vinci 5 Recall Posting, da Vinci SP Expansion, and Fresh Wall Street Targets Into the Christmas Trading Week

Date: December 21, 2025 (Sunday) Intuitive Surgical, Inc. (NASDAQ: ISRG) heads into the Christmas-shortened trading week with momentum—yet also with two developments investors will likely keep on the radar: a newly posted FDA Class 2 recall entry tied to a da Vinci 5 console component, and a recent FDA clearance that expands da Vinci SP into three high-volume general surgery…
22 December 2025
····
Intuitive Surgical (ISRG) Stock: Latest News, Analyst Forecasts, and 2026 Outlook (Updated Dec. 20, 2025)

Intuitive Surgical (ISRG) Stock: Latest News, Analyst Forecasts, and 2026 Outlook (Updated Dec. 20, 2025)

Intuitive Surgical, Inc. (NASDAQ: ISRG) is ending the week in focus after a strong Friday close, fresh regulatory momentum for its single-port platform, and a new wave of Wall Street price-target updates heading into 2026. As of Dec. 20, 2025 (Saturday)—with U.S. markets closed—investors are digesting what’s next for the surgical robotics leader following a volatile December trading range and…
21 December 2025
···
4DMedical (ASX:4DX) Share Price Surge: What Happened on 18 December 2025, Why CT:VQ Is Driving the Rally, and What Comes Next

4DMedical (ASX:4DX) Share Price Surge: What Happened on 18 December 2025, Why CT:VQ Is Driving the Rally, and What Comes Next

4DMedical (ASX:4DX) has become one of the most talked-about Australian small-cap healthcare names of late 2025—despite a bruising year for the broader sector. On 18 December 2025, fresh market coverage put the spotlight back on the stock’s extraordinary run and the commercial milestones behind it, as investors weighed a familiar question for fast-rising growth stories: is this the start of…
19 December 2025
····
Boston Scientific (BSX) Stock News Today: UBS Reiterates $140 Target, RBC Raises to $130 as 2026 Catalysts Come Into Focus

Boston Scientific (BSX) Stock News Today: UBS Reiterates $140 Target, RBC Raises to $130 as 2026 Catalysts Come Into Focus

Boston Scientific Corporation (NYSE: BSX) is back in the spotlight on Wednesday, December 17, 2025, as fresh Wall Street commentary and a new round of target-price updates reframe the conversation around the medtech leader’s 2026 setup—especially in fast-growing cardiac categories like electrophysiology (EP) and left atrial appendage closure (WATCHMAN). Investing While Boston Scientific shares have been under pressure recently—down nearly…
17 December 2025
····
WORK Medical Technology Group LTD (NASDAQ: WOK) Stock: Today’s News, Nasdaq Compliance Risks, Dilution Watch, and Forecasts (Dec. 15, 2025)

WORK Medical Technology Group LTD (NASDAQ: WOK) Stock: Today’s News, Nasdaq Compliance Risks, Dilution Watch, and Forecasts (Dec. 15, 2025)

December 15, 2025 — WORK Medical Technology Group LTD stock (Nasdaq: WOK) is back on traders’ radar as a hyper-volatile micro-cap with a story that reads like a corporate-actions speedrun: Nasdaq bid-price warnings, a 1-for-100 reverse stock split, rapid swings in market pricing, and fresh financing flexibility via an at-the-market (ATM) program. As of Dec. 15, 2025, market data platforms…
15 December 2025
····
Intuitive Surgical Stock News: ISRG Drops ~4% This Week Despite FDA Clearance, Citi Downgrade, and New Price Targets (Updated Dec. 12, 2025)

Intuitive Surgical Stock News: ISRG Drops ~4% This Week Despite FDA Clearance, Citi Downgrade, and New Price Targets (Updated Dec. 12, 2025)

Updated: Friday, December 12, 2025 (U.S. market close)Company: Intuitive Surgical, Inc. (NASDAQ: ISRG) Intuitive Surgical stock finished the week on the back foot—even as the robotic-surgery leader delivered a meaningful regulatory win. Shares of ISRG closed at $542.32 on Friday, Dec. 12, capping a five-session slide from $566.89 on Monday, Dec. 8 (a decline of roughly 4.3% across the week).…
13 December 2025
····
1 2 3 4

Stock Market Today

  • Moog (MOG.A) Valuation Appears Fair After DCF Check, But Upside Limited
    January 17, 2026, 2:06 PM EST. Moog Inc. trades near $291 after a strong multi-year run, with 6.7% weekly, 19.3% over 30 days, and 292.9% over five years. A Simply Wall St valuation pack gives Moog a 3/6 value score, reflecting mixed signals from different methods. A 2-stage Discounted Cash Flow (DCF) model pegs intrinsic value at about $299.78 per share, versus the $290.80 close, implying roughly a 3% discount and a fair value stance. The model uses Free Cash Flow to Equity (FCFE), with trailing FCF around $103.6 million and forecasts to 2027 of $273.8 million; projections extend to 2035. P/E remains a quick lens on price vs. earnings, but growth and risk shift the balance. In short, Moog looks fairly valued, but near-term catalysts matter.
Go toTop